Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

National Institute on Drug Abuse (NIDA)

Investor type Government Office

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 32
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 26
Rounds per year 0.67
Lead investments 11
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.19
Exits 6
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Life Science
Summary

We can highlight the next thriving fund investment areas, such as Medical, Non Profit. Among the most popular portfolio startups of the fund, we may highlight Peptide Logic.

Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year. The top activity for fund was in 2019.

The standard case for the fund is to invest in rounds with 1 partaker. Despite the National Institute on Drug Abuse (NIDA), startups are often financed by National Institutes of Health.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of National Institute on Drug Abuse (NIDA):
Typical Co-investors
National Institute on Drug Abuse (NIDA) is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after National Institute on Drug Abuse (NIDA):
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
2b AHEAD Ventures Germany, Leipzig, Saxony
Audax Private Equity Boston, Massachusetts, United States
CA Capital California, Sacramento, United States
Capital Access Holdings -
Deep Space Ventures Dallas, Texas, United States
DPI Energy Ventures -
Easter Egg Italy, Lombardy, Milan
GoldPoint Partners New York, New York, United States
ISEP Business Angels France, Ile-de-France, Paris
KB 1 Capital India -
Monsas Investment Bank England, London, United Kingdom
National Geographic Ventures District of Columbia, United States, Washington
Pix Vine Capital Central, Central Region, Singapore
Sherbrooke Innopole Canada, Quebec, Sherbrooke
Stonehenge Investments -
Suprema -
Tap4Fun Chengdu, China, Sichuan
Yingdu Wentou Beijing, Beijing, China
Zhejiang Collaborative Innovation North Investment Management Ltd. China, Hangzhou, Zhejiang
ZyQuest Inc. Technology and Development De Pere, United States, Wisconsin

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Achieve Life Science

Biotechnology
Life Science
Pharmaceutical
$2M01 Jun 2022 Mill Valley, California, United States

Evon Medics

Medical
Medical Device
Therapeutics
$2M09 May 2022 Maryland, United States

Case Western Reserve University - Crunchbase School Profile & Alumni

Education
Universities
$16M25 Oct 2021 Cleveland, Ohio, United States

Johns Hopkins University School of Medicine - Crunchbase School Profile & Alumni

Health Care
Hospitality
Training
$4M18 Oct 2021 Baltimore, Maryland, United States

BioCorRx

Biotechnology
Clinical Trials
Health Care
Medical
$3M01 Sep 2021 Anaheim, California, United States

Achieve Life Science

Biotechnology
Life Science
Pharmaceutical
$320K22 Jul 2021 Mill Valley, California, United States

Biopharma
Biotechnology
Health Care
Pharmaceutical
$8M05 Oct 2020 Little Rock, Arkansas, United States

Astellas Pharma

Biotechnology
Health Care
Medical
22 Jul 2020 Chiyoda

scite

Analytics
Artificial Intelligence
Information Technology
Machine Learning
Software
$1M14 May 2020 New York, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent National Institute on Drug Abuse (NIDA)?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: